News
Welcome to our website.
We hope that it has made you as enthusiastic about our technology as we are. This page has been written in a form that it can be easily updated, so please look it at regular intervals to see what is happening.
Our patent page might also be worth a visit.
- We have non exclusively licensed our technology to a multi-national cosmetic ingredients company for use in the decorative cosmetics market. A variety of cosmetic formulations have been manufactured and cosmetic products incorporating our technology were placed on the market late 2012.
- A Natural Solution to Photoprotection and Isolation of the Potent Polyene Antibiotic, Marinomycin A – protection against UV radiation and oxidation. https://pubs.rsc.org/en/content/articlepdf/2019/sc/c9sc01375j Received 21st March 2019 Accepted 20th May 2019 DOI: 10.1039/c9sc01375j
Data in our publications (includes data from human studies Sporomex has carried out) shows the ability of our microcapsule technology to orally deliver dietetic and pharmaceutical compounds:
- Enhanced Bioavailability of Eicosapentaenoic Acid (EPA) from Fish Oil After Encapsulation Within Plant Spore Exines as Microcapsules. Lipids, 2010, 45(7): 645-649. DOI: 10.1007/s11745-010-3427-y
- Lycopodium clavatum Exine Microcapsules Enable Safe Oral Delivery of 3,4-Diaminopyridine for Treatment of Botulinum Neurotoxin A Intoxication, Tyler L Harris, Cody J Wenthur, Alberto Diego-Taboada, Grahame Mackenzie, Terry S Corbitt, Kim D Janda, Chemical Communications, Thursday February 18th 2016 DOI:10.1039/C6CC00615A
- Spore exines increase vitamin D clinical bioavailability by mucoadhesion and bile triggered release. Journal of controlled release, 2022, 350, 244-255. DOI: 10.1016/j.jconrel.2022.08.017